Bacterial resistance to beta-lactams, and its prevention with combination antimicrobial therapy.
about
In vitro synergistic activities of tobramycin and selected beta-lactams against 75 gram-negative clinical isolates.The role of antimicrobial peptides in preventing multidrug-resistant bacterial infections and biofilm formation.Short, Synthetic Cationic Peptides Have Antibacterial Activity against Mycobacterium smegmatis by Forming Pores in Membrane and Synergizing with Antibiotics.Synergy with rifampin and kanamycin enhances potency, kill kinetics, and selectivity of de novo-designed antimicrobial peptides.
P2860
Bacterial resistance to beta-lactams, and its prevention with combination antimicrobial therapy.
description
1992 nî lūn-bûn
@nan
1992 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Bacterial resistance to beta-l ...... ination antimicrobial therapy.
@ast
Bacterial resistance to beta-l ...... ination antimicrobial therapy.
@en
type
label
Bacterial resistance to beta-l ...... ination antimicrobial therapy.
@ast
Bacterial resistance to beta-l ...... ination antimicrobial therapy.
@en
prefLabel
Bacterial resistance to beta-l ...... ination antimicrobial therapy.
@ast
Bacterial resistance to beta-l ...... ination antimicrobial therapy.
@en
P1433
P1476
Bacterial resistance to beta-l ...... bination antimicrobial therapy
@en
P2093
Barriere SL
P304
P407
P577
1992-01-01T00:00:00Z